Improving outcomes with long-term “destination” therapy using left ventricular assist devices

The Journal of Thoracic and Cardiovascular Surgery - Tập 135 - Trang 1353-1361 - 2008
James W. Long1, Aaron H. Healy1, Brad Y. Rasmusson1, Cris G. Cowley1, Karl E. Nelson1, Abdallah G. Kfoury1, Stephen E. Clayson1, Bruce B. Reid1, Stephanie A. Moore2, Douglas U. Blank3, Dale G. Renlund1
1Utah Artificial Heart Program, LDS Hospital, Salt Lake City, Utah
2Massachusetts General Hospital, Boston, Mass.
3Idaho Heart Institute, Idaho Falls, Idaho

Tài liệu tham khảo

2005 Pennington, 1994, Eight years' experience with bridging to cardiac transplantation, J Thorac Cardiovasc Surg, 107, 472, 10.1016/S0022-5223(94)70092-3 Frazier, 1992, Multicenter clinical evaluation of the HeartMate IP left ventricular assist device, Ann Thorac Surg, 53, 1080, 10.1016/0003-4975(92)90393-I Catanese, 1996, Outpatient left ventricular assist device support: a destination rather than a bridge, Ann Thorac Surg, 62, 646, 10.1016/S0003-4975(96)00456-0 Rose, 2001, Long-term use of a left ventricular assist device for end-stage heart failure, N Engl J Med, 345, 1435, 10.1056/NEJMoa012175 Long, 2005, Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH Study, Congest Heart Fail, 11, 133, 10.1111/j.1527-5299.2005.04540.x Rose, 1999, The REMATCH trial: rationale, design, and end points, Ann Thorac Surg, 67, 723, 10.1016/S0003-4975(99)00042-9 Park, 2005, Left ventricular assist devices as destination therapy: a new look at survival, J Thorac Cardiovasc Surg, 129, 9, 10.1016/j.jtcvs.2004.04.044 McKellar, 1999, Treatment of infected left ventricular assist device using antibiotic-impregnated beads, Ann Thorac Surg, 67, 554, 10.1016/S0003-4975(98)01243-0 Mielniczuk, 2004, Patient selection for left ventricular assist devices, Artif Organs, 28, 152, 10.1111/j.1525-1594.2003.47333.x Richenbacher, 2003, Surgical management of patients in the REMATCH trial, Ann Thorac Surg, 75, S86, 10.1016/S0003-4975(03)00485-5 Holman, 2004, Infection in permanent circulatory support: experience from the REMATCH trial, J Heart Lung Transplant, 23, 1359, 10.1016/j.healun.2003.09.025 Lazar, 2004, Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience, Circulation, 109, 2423, 10.1161/01.CIR.0000129414.95137.CD Dowling, 2004, HeartMate VE LVAS design enhancements and its impact on device reliability, Eur J Cardiothoracic Surg, 25, 958, 10.1016/j.ejcts.2004.03.003 Rao, 2004, Changing trends in mechanical circulatory assistance: experience with 131 consecutive HeartMate VE left ventricular assist devices, J Card Surg, 19, 361, 10.1111/j.0886-0440.2004.4074_11.x Oz, 1995, Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices, Circulation, 92, II169, 10.1161/01.CIR.92.9.169 Long, 2001, Advanced mechanical circulatory support with the HeartMate left ventricular assist device in the year 2000, Ann Thorac Surg, 71, S176, 10.1016/S0003-4975(00)02635-7 Song, 2003, Axial flow blood pumps, ASAIO J, 49, 355 Takatani, 2002, Beyond implantable first generation cardiac prostheses for treatment of end-stage cardiac patients with clinical results in a multicenter, Ann Thorac Cardiovasc Surg, 8, 253 Deng, 2002, Cardiac transplantation, Heart, 87, 177, 10.1136/heart.87.2.177